Vertex Pharmaceuticals, Inc. (VRTX) is scheduled to report first-quarter 2017 results on Apr 27, after the market closes.
- Motley Fool•yesterday
Allergan, Express Scripts, and Vertex stocks look attractive in a generally overpriced market.
- Motley Fool•2 days ago
Impressive growth could be in store for biotech stocks Celgene, Ionis, and Vertex.
VRTX : Summary for Vertex Pharmaceuticals Incorpor - Yahoo Finance
Vertex Pharmaceuticals Incorpor (VRTX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||117.45 x 200|
|Ask||117.47 x 200|
|Day's Range||117.07 - 118.39|
|52 Week Range||71.46 - 118.79|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-254.74|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|